Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Amortizatization of Intangibles (2020 - 2023)

Mirum Pharmaceuticals (MIRM) has 4 years of Amortizatization of Intangibles data on record, last reported at $29000.0 in Q4 2023.

  • For Q4 2023, Amortizatization of Intangibles fell 97.15% year-over-year to $29000.0; the TTM value through Dec 2023 reached $1.7 million, up 1.29%, while the annual FY2023 figure was $1.7 million, 1.29% up from the prior year.
  • Amortizatization of Intangibles reached $29000.0 in Q4 2023 per MIRM's latest filing, down from $234000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $1.0 million in Q4 2022 and bottomed at -$192000.0 in Q3 2020.
  • Average Amortizatization of Intangibles over 4 years is $242687.5, with a median of $97500.0 recorded in 2021.
  • Peak YoY movement for Amortizatization of Intangibles: plummeted 142.29% in 2021, then skyrocketed 31550.0% in 2023.
  • A 4-year view of Amortizatization of Intangibles shows it stood at $350000.0 in 2020, then crashed by 142.29% to -$148000.0 in 2021, then soared by 787.16% to $1.0 million in 2022, then plummeted by 97.15% to $29000.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Amortizatization of Intangibles were $29000.0 in Q4 2023, $234000.0 in Q3 2023, and $633000.0 in Q2 2023.